GURU.Markets stock price, segment price, and overall market index valuation
The company's share price BLCO
Bausch + Lomb is one of the oldest and most recognizable brands in eye health. The stock price of this spinoff company reflects the stable demand for contact lenses, solutions, and ophthalmic equipment, driven by demographic factors.
Share prices of companies in the market segment - Pharma eyes
Bausch + Lomb is a global eye care company with products ranging from contact lenses to surgical equipment. We classify it as part of the Pharmaceutical Eyes sector. The chart below shows the overall performance of this stable healthcare segment.
Broad Market Index - GURU.Markets
Bausch + Lomb is a leading global eye care company, offering a wide range of products, from contact lenses to surgical equipment. As a global brand, it is included in the GURU.Markets index. The chart below shows the overall market trend. Compare it with Bausch + Lomb's performance to assess the state of the ophthalmology sector.
Change in the price of a company, segment, and market as a whole per day
BLCO - Daily change in the company's share price BLCO
The volatility of Bausch + Lomb (BLCO), a global vision company (contact lenses, surgical products), is reflected in Change_Co, which is sensitive to innovation, regulatory approvals, and healthcare spending. Change_Co is a measure of exposure to the medical sector. In System.GURU.Markets formulas, it is important for assessing the dynamics of the ophthalmology sector.
Daily change in the price of a set of shares in a market segment - Pharma eyes
Bausch + Lomb Corporation is an iconic brand in eye health. This chart shows the average daily volatility of the healthcare sector. Comparing it to BLCO, with its diversification from contact lenses to surgical equipment, helps assess its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Bausch + Lomb is an iconic brand in eye health, producing contact lenses, solutions, and ophthalmic medications. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess how Bausch + Lomb is responding to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization BLCO
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. Its year-over-year growth reflects stable demand driven by demographic trends and the need for vision correction.
Annual dynamics of market capitalization of the market segment - Pharma eyes
Bausch + Lomb Corporation is a global ophthalmology company with a diversified portfolio including contact lenses, surgical equipment, and pharmaceuticals. The chart shows how its strong brand and broad market reach contribute to its consistent growth in the healthcare sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bausch + Lomb, a global eye health company, operates in the protective eye care sector. Demand for contact lenses, eye drops, and surgical equipment is stable and unaffected by economic cycles. The company's stock price reflects sustainable growth driven by demographic trends and the ongoing need for good vision.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization BLCO
Bausch + Lomb's performance, an eye care company, reflects stable demand. Monthly fluctuations in the chart are driven by sales of its portfolio of contact lenses, surgical equipment, and pharmaceuticals, demand for which is supported by demographic trends such as an aging population.
Monthly dynamics of market capitalization of the market segment - Pharma eyes
This chart reflects the dynamics of the medical technology sector, particularly in ophthalmology. For Bausch + Lomb, with its diversified portfolio, this provides context. Its movements reflect demand for its contact lenses, surgical equipment, and pharmaceuticals.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bausch + Lomb Corporation is a global ophthalmology company with a history spanning over 170 years. Its diversified portfolio includes contact lenses, pharmaceuticals, and surgical equipment. The broader market graph allows us to assess how stable demand for vision care, driven by demographics, has made its business resilient to economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization BLCO
Bausch + Lomb is a global leader in eye health. Its weekly stock price reflects news of new drug and lens approvals, demographic trends related to an aging population, and overall sentiment in the healthcare sector. This chart shows how the market views innovations in ophthalmology.
Weekly dynamics of market capitalization of the market segment - Pharma eyes
Bausch + Lomb is a pharmaceutical company that frequently responds to industry-wide events, such as healthcare reforms or major M&A deals. The chart compares the company's performance with the overall health of its large and diverse segment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Bausch + Lomb is an ophthalmology company. The healthcare sector is considered defensive, but to what extent? The chart will reveal whether the company's shares are truly weakly responsive to market fluctuations, or whether their reliance on elective procedures and consumer spending makes them sensitive to economic cycles.
Market capitalization of the company, segment and market as a whole
BLCO - Market capitalization of the company BLCO
Bausch + Lomb's market capitalization reflects demographic trends and the continued demand for vision care. This chart shows how investors value the company's product portfolio, from contact lenses to surgical equipment. It's a story of a business growing alongside an aging population.
BLCO - Share of the company's market capitalization BLCO within the market segment - Pharma eyes
Bausch + Lomb is a century-old global company focused on eye health. Its significant market share in the ophthalmology sector reflects its strong brand and broad product portfolio, from lenses to surgical equipment. The chart shows how demographics and innovation support its stable market share.
Market capitalization of the market segment - Pharma eyes
Bausch + Lomb is a global company dedicated to eye health, from contact lenses to surgical equipment. What is the overall size of this industry? The chart below shows the total market capitalization of the ophthalmology sector. Its steady growth reflects the global need for vision correction and eye disease treatment.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Bausch + Lomb chart represents the financial valuation of one of the most recognizable brands in eye health. The company's market capitalization, which produces contact lenses, solutions, and ophthalmological equipment, reflects stable demand driven by demographics and the need for vision correction. This is a graph of sustainable growth.
Book value capitalization of the company, segment and market as a whole
BLCO - Book value capitalization of the company BLCO
Bausch + Lomb's physical assets are its factories producing contact lenses, ophthalmic products, and surgical equipment, as well as its research and development centers. Book value reflects the value of this global production network. The chart below shows the dynamics of the value of this physical capital.
BLCO - Share of the company's book capitalization BLCO within the market segment - Pharma eyes
Bausch + Lomb is not only a brand but also a powerful manufacturing and research base. The company owns factories for contact lenses, pharmaceuticals, and surgical equipment worldwide. The graph below shows the share of this high-tech medical infrastructure controlled by the ophthalmology giant.
Market segment balance sheet capitalization - Pharma eyes
Bausch + Lomb is a global company with factories producing lenses, pharmaceuticals, and equipment. This makes its business capital-intensive, requiring investment in high-tech production. The graph below illustrates the scale of the entire ophthalmology sector.
Book value of all companies included in the broad market index - GURU.Markets
Bausch + Lomb is a veteran in the vision care industry. The company's assets include lens and solution manufacturing plants, as well as R&D centers. Its stake in BCap_All reflects the scale of its ability to manufacture products that impact the lives of hundreds of millions of people worldwide.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - BLCO
Bausch + Lomb is a century-old ophthalmology brand, but its balance sheet consists solely of factories and equipment. The market values the company significantly higher, factoring in the brand value, the trust of doctors and patients, and its patent portfolio. The P/B chart shows the premium for this intangible legacy.
Market to book capitalization ratio in a market segment - Pharma eyes
Bausch + Lomb is a global ophthalmology company that produces lenses, pharmaceuticals, and surgical equipment. This metric reflects the premium the market places on a strong brand, patent portfolio, and scientific developments over the value of its production facilities and laboratories.
Market to book capitalization ratio for the market as a whole
Bausch + Lomb is a leading eye care company, producing contact lenses, pharmaceuticals, and surgical equipment. Compared to average market valuations, as shown in this chart, its valuation reflects the strength of its brand and stable demand driven by demographic factors such as an aging population.
Debts of the company, segment and market as a whole
BLCO - Company debts BLCO
Bausch + Lomb, a global leader in eye health, uses debt to finance innovation and growth. The company uses debt for research and development of new lenses, pharmaceuticals, and surgical equipment, as well as for strategic acquisitions, strengthening its position in all segments of the ophthalmology market.
Market segment debts - Pharma eyes
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. To remain competitive, the company must continually invest in research and development of new products. This chart shows how the company funds its innovation and how aggressively it seeks to expand its market share.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio BLCO
Bausch + Lomb is a global company dedicated to eye health, from contact lenses to surgical equipment. Maintaining its leadership requires continuous investment in research and development, as well as marketing. This chart illustrates how the company leverages debt to fund its innovation pipeline and global presence.
Market segment debt to market segment book capitalization - Pharma eyes
Bausch + Lomb is a global eye care company that manufactures lenses, pharmaceuticals, and surgical equipment. This chart shows the debt burden in the ophthalmic pharmaceutical sector. It helps understand how the industry funds expensive research and development, and how Bausch + Lomb manages its capital after the spinoff.
Debt to book value of all companies in the market
Bausch + Lomb is a global eye care company in a less cyclical sector. This chart shows the overall debt level in the market. It allows one to assess how Bausch + Lomb's stable business compares to overall macroeconomic fluctuations and how the company uses its leverage for acquisitions and growth within its industry.
P/E of the company, segment and market as a whole
P/E - BLCO
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. This chart shows the market's assessment of its ability to generate stable profits. Demand for its products is supported by demographic trends such as an aging population, which provides confidence to investors.
P/E of the market segment - Pharma eyes
The eye care industry, where Bausch + Lomb is a leader, is growing steadily. This chart shows the average valuation for companies in the healthcare sector. It helps understand the premium investors pay for Bausch + Lomb's recognizable brand and diversified product portfolio compared to other healthcare companies.
P/E of the market as a whole
Bausch + Lomb is a global eye care company. It produces contact lenses, pharmaceuticals, and surgical equipment. Demand for its products is driven by medical needs and demographic trends (such as an aging population), making its business relatively stable and less dependent on economic cycles, as shown in this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company BLCO
Bausch + Lomb is a global eye care company producing contact lenses, pharmaceuticals, and surgical equipment. Future profits are driven by demographic trends and product innovations. This chart reflects analyst expectations for ophthalmology market growth and the success of the company's new products.
%20P%2FE%20BLCO&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-BLCO&v=1772567605394 "Chart of the company's future (projected) P/E BLCO")
Future (projected) P/E of the market segment - Pharma eyes
Bausch + Lomb is a global ophthalmology company offering a wide range of products, from contact lenses to surgical equipment. The chart shows how the company's revenue forecasts compare to the healthcare sector average. This reflects how the market values its strong brand and diversified portfolio in the face of an aging population.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-eyes&v=1772567605512 "Future (projected) P/E graph of the market segment - Pharma eyes")
Future (projected) P/E of the market as a whole
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. This chart shows the overall economic sentiment. B+L's business is relatively defensive: vision problems require solutions regardless of the economic climate, ensuring the company has stable demand for its products and services.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772567605562 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit BLCO
Bausch + Lomb is a global eye care company. It produces contact lenses, solutions, ophthalmic medications, and surgical equipment. The financial results in this chart reflect the stable demand for its products, driven by demographic factors such as an aging population and the prevalence of vision problems.
Profit of companies in the market segment - Pharma eyes
Bausch + Lomb is a global eye care company. It produces contact lenses, solutions, pharmaceuticals, and ophthalmic surgical equipment. This chart shows the overall financial picture of the vision care industry, which is growing thanks to an aging population and the introduction of innovative products.
Overall market profit
Bausch + Lomb is a global eye care company. It produces contact lenses, pharmaceuticals, and surgical equipment. Demand for most of its products is non-cyclical, as vision care is a necessity. This ensures the company's stable revenue even during periods of economic instability, as shown in the chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company BLCO
Bausch + Lomb is one of the oldest and most respected companies in the eye care industry, producing contact lenses, solutions, and surgical equipment. Demand for its products is stable thanks to demographic trends. This chart shows the profit forecast based on growth expectations for its key segments.
%20profit%20of%20the%20company%20BLCO&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-BLCO&v=1772567605733 "Graph of future (projected) profit of the company BLCO")
Future (predicted) profit of companies in the market segment - Pharma eyes
Bausch + Lomb is a global company focused entirely on eye health, from contact lenses and solutions to surgical equipment and ophthalmic medications. This chart reflects stable expectations for the healthcare sector. The aging demographic trend ensures long-term and sustainable demand for Bausch + Lomb's products and services.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-eyes&v=1772567605760 "Graph of future (predicted) profits of companies in a market segment - Pharma eyes")
Future (predicted) profit of the market as a whole
Bausch + Lomb is a global eye care company. Demand for its products, such as contact lenses and surgical equipment, is generally stable. However, some segments, such as premium products, can be sensitive to economic downturns. This chart helps assess overall consumer confidence and healthcare budgets.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772567605792 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - BLCO
Bausch + Lomb is a global eye care company that produces contact lenses, pharmaceuticals, and surgical equipment. This chart shows how the market values its revenue across various ophthalmology segments. It reflects confidence in stable demand driven by demographic trends.
P/S market segment - Pharma eyes
Bausch + Lomb is a global ophthalmology company offering a wide range of products, from contact lenses to surgical equipment. Its revenue is driven by innovation and demographic trends. This chart shows how the market values companies in the healthcare sector, which helps determine how investors value the Bausch + Lomb brand and product portfolio.
P/S of the market as a whole
Bausch + Lomb is a global eye care company. It produces contact lenses, solutions, ophthalmic medications, and surgical equipment. This average market revenue valuation chart shows the premium investors are willing to pay for the company's earnings, operating in the stable and growing healthcare market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company BLCO
Bausch + Lomb is a global eye care company offering a wide range of products, from contact lenses to surgical equipment. This chart shows how the market estimates the company's future revenue, which is influenced by demographic trends such as an aging population, innovations in ophthalmology, and consumer spending.
%20P%2FS%20BLCO&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-BLCO&v=1772567605908 "The graph of the company's future (projected) P/S BLCO")
Future (projected) P/S of the market segment - Pharma eyes
Bausch + Lomb is a global eye care company offering a wide range of products, from contact lenses to surgical equipment. This chart compares the company's estimated future sales with the healthcare sector. It helps understand how the market views its product portfolio and prospects against the backdrop of an aging population.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-eyes&v=1772567605943 "Future (projected) P/S market segment graph - Pharma eyes")
Future (projected) P/S of the market as a whole
Bausch + Lomb is a global eye care company with a product portfolio ranging from contact lenses to surgical devices. This chart illustrates general expectations, and Bausch + Lomb represents a segment with stable demand driven by demographics and healthcare needs. Its revenue adds an element of predictability to the overall market forecast.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772567605949 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales BLCO
Bausch + Lomb is a global company focused on eye health. Its revenue, shown in this chart, is comprised of sales from three segments: contact lenses and solutions, ophthalmic pharmaceuticals, and surgical equipment and implants. The dynamics reflect the demand for vision correction and treatment products.
Sales of companies in the market segment - Pharma eyes
Bausch + Lomb is a global company focused on eye health, with products ranging from contact lenses to surgical equipment. Their revenue reflects both demographic trends (an aging population) and innovations in ophthalmology. This chart shows the dynamics of the entire vision care market, where Bausch + Lomb's comprehensive portfolio delivers stable growth.
Overall market sales
Bausch + Lomb, a global ophthalmology company, operates in a market that combines necessary and discretionary spending. The growth in overall revenue shown here influences consumers' willingness to spend on more expensive contact lenses, new glasses, and even surgical procedures. This complements the stable demand for medications and basic eye care products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company BLCO
Bausch + Lomb is a global eye care company with products in contact lenses, pharmaceuticals, and surgical equipment. The sales forecast reflects demographic trends such as an aging population and the growing need for vision correction. It also provides expected demand for the company's entire range of ophthalmic solutions.
%20sales%20of%20the%20company%20BLCO&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-BLCO&v=1772567606081 "Schedule of future (projected) sales of the company BLCO")
Future (projected) sales of companies in the market segment - Pharma eyes
Bausch + Lomb is a global eye care company. It produces contact lenses, solutions, ophthalmic medications, and surgical equipment. This chart shows forecasts for the pharmaceutical industry, helping to assess how demographic trends (aging population) and innovation impact Bausch + Lomb's prospects.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-eyes&v=1772567606140 "Schedule of future (projected) sales of companies in the market segment - Pharma eyes")
Future (projected) sales of the market as a whole
Bausch + Lomb, a company specializing in eye health, sees this chart as an indicator of access to healthcare. Economic and income growth, reflected here, allows more people to spend money on high-quality contact lenses, solutions, and surgical procedures, expanding the market for the company's entire product range.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772567606157 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality BLCO
Bausch + Lomb is a global eye care company that produces contact lenses, pharmaceuticals, and surgical equipment. This chart shows the percentage of revenue the company retains as profit. It reflects the profitability of its diversified product portfolio, from consumer lenses to high-tech ophthalmology equipment.
Market segment marginality - Pharma eyes
Bausch + Lomb is a global eye care company with a product portfolio that includes contact lenses, surgical equipment, and pharmaceuticals. This chart compares the company's profitability with other players in the healthcare sector. Its strong margins may be due to its recognizable brands and innovative products.
Market marginality as a whole
#VALUE!
Employees in the company, segment and market as a whole
Number of employees in the company BLCO
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. This chart shows the scale of its team, spanning research, manufacturing, and sales. The growth in staff reflects investments in new product development and expanding its commercial presence in the global ophthalmology market.
Share of the company's employees BLCO within the market segment - Pharma eyes
Bausch + Lomb is a global company with a nearly 170-year history in ophthalmology. From contact lenses to surgical equipment, everything requires a team of scientists and specialists. This chart reflects the company's share of the ophthalmology industry's talent pool, demonstrating its historical weight and leadership.
Number of employees in the market segment - Pharma eyes
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. This chart shows its global workforce, including researchers, production workers, and sales professionals. The headcount trend reflects investments in R&D, new product launches, and international expansion.
Number of employees in the market as a whole
Bausch + Lomb is a global company specializing in eye health, from contact lenses to surgical equipment. Demand for its products is stable and driven by demographic factors such as an aging population. This chart illustrates the general economic dynamics, against which Bausch + Lomb represents a healthcare sector with stable employment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company BLCO (BLCO)
Bausch + Lomb is a global ophthalmology company that manufactures contact lenses, pharmaceuticals, and surgical equipment. Its business combines R&D, manufacturing, and sales, requiring a large and diverse workforce. The moderate value on this chart reflects this complex and multifaceted business model.
%20of%20the%20company%20BLCO%20(BLCO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-BLCO-BLCO&v=1772567606387 "Chart of market capitalization per employee (in thousands of dollars) of the company BLCO (BLCO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma eyes
Bausch + Lomb is an iconic name in eye health. They produce contact lenses, solutions, ophthalmic pharmaceuticals, and surgical equipment. This chart reflects the average capitalization per employee in the sector. It shows how the market values their diversified portfolio and strong brand per employee.
%20by%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-eyes&v=1772567606420 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma eyes")
Market capitalization per employee (in thousands of dollars) for the overall market
Bausch + Lomb is a global ophthalmology company that produces contact lenses, pharmaceuticals, and surgical equipment. Its value lies in strong brands, patents, and distribution. This chart shows how investors value a business where R&D and marketing generate high added value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772567606458 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company BLCO (BLCO)
Bausch + Lomb is a global company specializing in eye health (contact lenses, surgical equipment, pharmaceuticals). This chart demonstrates the efficiency of their diversified business. It reflects how efficiently the company generates revenue from each employee—from the researcher in the lab to the sales representative working with ophthalmologists.
%20Chart%20BLCO%20(BLCO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-BLCO-BLCO&v=1772567606462 "Company Profit Per Employee (in thousands of dollars) Chart BLCO (BLCO)")
Profit per employee (in thousands of dollars) in the market segment - Pharma eyes
Bausch + Lomb (BLCO) is an iconic brand in eye health (contact lenses, surgery, and eye drops). This chart shows the benchmark for Pharma Eyes (Medtech). In this sector, the benchmark is high. It's a brand-focused business with consumables (lenses and eye drops) that generate stable, high-margin profits.
%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-eyes&v=1772567606605 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma eyes")
Profit per employee (in thousands of dollars) for the market as a whole
Bausch + Lomb (BLCO) is one of the oldest and most renowned ophthalmology companies in the world. They produce contact lenses (Bausch + Lomb), surgical equipment, and ophthalmic pharmaceuticals. This chart, which shows the average profit per employee across the market, helps us understand how the healthcare sector, where R&D and branding create high added value, outperforms the "average" labor efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772567606637 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee BLCO (BLCO)
Bausch + Lomb is a global eye care company. This chart shows how their extensive product portfolio, from contact lenses to surgical devices, translates into revenue. It reflects the performance of the entire team, including researchers, manufacturing personnel, and their global sales network.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-BLCO-BLCO&v=1772567606720 "Sales chart per company employee BLCO (BLCO)")
Sales per employee in the market segment - Pharma eyes
Bausch + Lomb is a century-old company specializing in eye care (lenses, surgical equipment, pharmaceuticals). This chart shows the average revenue per employee in this segment. It allows you to assess how effectively Bausch + Lomb manages its diversified portfolio and global workforce compared to other players in the ophthalmology market.
Sales per employee for the market as a whole
Bausch + Lomb is one of the oldest eye care companies in the world. They produce lenses, solutions, pharmaceuticals, and surgical equipment. This chart shows how efficiently the company generates revenue per employee across its various segments—from mass-market lenses to complex surgical equipment.
Short shares by company, segment and market as a whole
Shares shorted by company BLCO (BLCO)
Bausch + Lomb is a global company focused on eye health. It produces contact lenses, surgical equipment, and pharmaceuticals. The chart shows the number of investors who are skeptical. They may bet that the company will struggle to compete on price in the lens market or that its new products will fail to gain market share.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-BLCO-BLCO&v=1772567606776 "Short Shares Chart for the Company BLCO (BLCO)")
Shares shorted by market segment - Pharma eyes
Bausch + Lomb is a well-known eye care brand that produces contact lenses, solutions, and surgical equipment. This chart shows the total short position across the sector. It helps understand whether investors expect a decline in consumer spending on vision care or a slowdown in elective eye surgeries.
Shares shorted by the overall market
Bausch + Lomb (BLCO) is a giant in eye care (lenses, surgery). It's a "defensive" sector. However, a rising Short_All chart signals recession fears. This pessimism is causing patients to cut corners by postponing elective surgeries (such as cataract surgery) or choosing cheaper lenses, which puts pressure on BLCO's margins.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator BLCO (BLCO)
Bausch + Lomb, spun off from Bausch Health, produces contact lenses, eye care equipment, and medications. The business is relatively stable. A BLCO above 70 may reflect strong sales or the success of new products. A BLCO below 30 may reflect concerns about competition or debt issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-BLCO-BLCO&v=1772567606844 "RSI 14 indicator chart for the company's stock BLCO (BLCO)")
RSI 14 Market Segment - Pharma eyes
Bausch + Lomb (BLCO) is a legendary name in ophthalmology. They produce contact lenses, surgical equipment, and pharmaceuticals for eye health. This chart shows the collective sentiment in the Pharmaceuticals/Eye Care sector. It helps distinguish BLCO's performance from general overheating or overselling in the overall vision care industry.
RSI 14 for the overall market
Bausch + Lomb is a renowned global brand that produces contact lenses, solutions, and ophthalmic equipment. Vision is a basic need, making the business "defensive." However, this schedule is still important. During times of panic, consumers may postpone routine lens replacements or new glasses, and investors may fear a general downturn in the sector.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BLCO (BLCO)
Bausch + Lomb is a well-known eye care company. It produces contact lenses (Bausch + Lomb, Biotrue), solutions, as well as pharmaceuticals and surgical equipment for ophthalmology. This chart summarizes analyst expectations for the 12-month target price of BLCO stock.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BLCO-BLCO&v=1772567606893 "A chart showing analyst consensus forecasts for the expected stock price. BLCO (BLCO)")
The difference between the consensus estimate and the actual stock price BLCO (BLCO)
Bausch + Lomb is an iconic eye care company. They produce contact lenses (B&L, Biotrue), solutions, as well as surgical equipment and pharmaceuticals for ophthalmology. This chart shows analysts' estimates of their product portfolio and new lens launches. It reflects the gap between the consensus forecast and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BLCO-BLCO&v=1772567606924 "A chart showing the difference between the consensus forecast and the actual stock price. BLCO (BLCO)")
Analyst consensus forecast for stock prices by market segment - Pharma eyes
Bausch + Lomb is a pillar of the eye care industry. The company produces contact lenses (Bausch + Lomb Ultra), surgical equipment, and ophthalmic medications. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe the vision care market will grow, driven by an aging population.
Analysts' consensus forecast for the overall market share price
Bausch + Lomb (BLCO) is an ophthalmology giant. They have three segments: vision (lenses, solutions), surgery (equipment), and pharmaceuticals (drops). This graph, reflecting expert expectations, influences them. During a downturn (pessimism), their surgery segment suffers (people postpone planned lens replacements), but lenses (consumables) remain stable.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index BLCO
Bausch + Lomb is a historic ophthalmology brand that was recently spun off into a separate company. They have three segments: contact lenses (Vision Care), surgical equipment, and pharmaceuticals (eye drops). This chart is a summary indicator of eye health. It reflects the stable demand for lenses and the aging demographic trend (increasing cataract surgery).
AKIMA Market Segment Index - Pharma eyes
Bausch + Lomb (BLCO) is a global vision care veteran (spinned off from BHC) with a diversified portfolio spanning contact lenses, surgery (cataracts), and eye drops. This composite metric evaluates companies. The chart shows the sector average. This benchmark provides insight into how B+L's diversified (lenses and surgery) portfolio differentiates it from the average competitor.
The AKIM Index for the overall market
Bausch + Lomb is an eye care giant spun off from BHC. The company produces everything from contact lenses to surgical equipment. This chart, reflecting the market average, is a backdrop. It helps assess how this eye care business (dependent on elective surgeries) compares to the overall macroeconomic fluctuations reflected by this indicator.
